People with diabetes and hypovitaminosis C fail to conserve urinary vitamin C.
Autorzy:
Lunt H; Diabetes Outpatients, Te Whatu Ora Waitaha Canterbury, Christchurch 8011, New Zealand.; Department of Medicine, University of Otago, Christchurch. 2 Riccarton Ave, Christchurch 8011, New Zealand. Carr AC; Nutrition in Medicine Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch. 2 Riccarton Ave, Christchurch 8011, New Zealand. Heenan HF; Diabetes Outpatients, Te Whatu Ora Waitaha Canterbury, Christchurch 8011, New Zealand. Vlasiuk E; Nutrition in Medicine Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch. 2 Riccarton Ave, Christchurch 8011, New Zealand. Zawari M; Nutrition in Medicine Research Group, Department of Pathology and Biomedical Science, University of Otago, Christchurch. 2 Riccarton Ave, Christchurch 8011, New Zealand. Prickett T; Department of Medicine, University of Otago, Christchurch. 2 Riccarton Ave, Christchurch 8011, New Zealand. Frampton C; Department of Medicine, University of Otago, Christchurch. 2 Riccarton Ave, Christchurch 8011, New Zealand.
High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis.
Autorzy:
Schmalz F; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Fischer J; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. Innes H; School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK. Buch S; Medical Department 1, University Hospital Dresden, Technische Universität Dresden, Dresden, Germany. Möller C; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Matz-Soja M; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. von Schönfels W; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, and Christian-Albrecht University (CAU), Kiel, Germany. Krämer B; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Langhans B; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Klüners A; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Soyka M; Psychiatric Hospital, Ludwig Maximilians University, Munich, Germany. Stickel F; Department of Gastroenterology and Hepatology, University Hospital of Zürich, Switzerland. Nattermann J; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Strassburg CP; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Berg T; Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany. Lutz P; Department of Internal Medicine I, University Hospital, University of Bonn, Germany. Nischalke HD; Department of Internal Medicine I, University Hospital, University of Bonn, Germany.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2023 Jan 25; Vol. 5 (4), pp. 100684. Date of Electronic Publication: 2023 Jan 25 (Print Publication: 2023).
Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis.
Autorzy:
Crudele L; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. De Matteis C; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy.; INBB National Institute for Biostructure and Biosystems, Viale delle Medaglie d'Oro 305 - 00136 Roma, Italy. Piccinin E; Department of Basic Medical Science, Neurosciences and Sense organs, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Gadaleta RM; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Cariello M; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Di Buduo E; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Piazzolla G; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Suppressa P; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Berardi E; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Sabbà C; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy. Moschetta A; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', Piazza Giulio Cesare 11, 70124 Bari, Italy.; INBB National Institute for Biostructure and Biosystems, Viale delle Medaglie d'Oro 305 - 00136 Roma, Italy.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2022 Nov 15; Vol. 5 (1), pp. 100627. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2023).
Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
Autorzy:
Luo Y; Bristol Myers Squibb, Princeton, NJ, USA. Decato BE; Bristol Myers Squibb, Princeton, NJ, USA. Charles ED; Bristol Myers Squibb, Princeton, NJ, USA. Shevell DE; Bristol Myers Squibb, Princeton, NJ, USA. McNaney C; Bristol Myers Squibb, Princeton, NJ, USA. Shipkova P; Bristol Myers Squibb, Princeton, NJ, USA. Apfel A; Bristol Myers Squibb, Princeton, NJ, USA. Tirucherai GS; Bristol Myers Squibb, Princeton, NJ, USA. Sanyal AJ; Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Nov 12; Vol. 4 (1), pp. 100392. Date of Electronic Publication: 2021 Nov 12 (Print Publication: 2022).
Restricting carbohydrates and calories in the treatment of type 2 diabetes: a systematic review of the effectiveness of 'low-carbohydrate' interventions with differing energy levels.
Autorzy:
Nicholas AP; Department of Nutritional Sciences, University of Surrey, Guildford, UK. Soto-Mota A; Department of Physiology, Anatomy & Genetics, University of Oxford, Oxford, UK. Lambert H; Department of Nutritional Sciences, University of Surrey, Guildford, UK. Collins AL; Department of Nutritional Sciences, University of Surrey, Guildford, UK.
Pokaż więcej
Źródło:
Journal of nutritional science [J Nutr Sci] 2021 Sep 14; Vol. 10, pp. e76. Date of Electronic Publication: 2021 Sep 14 (Print Publication: 2021).
Hepatic microbiome in healthy lean and obese humans.
Autorzy:
Suppli MP; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Bagger JI; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Lelouvier B; Vaiomer, Labège, France. Broha A; Vaiomer, Labège, France. Demant M; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Kønig MJ; Department of Radiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Strandberg C; Department of Radiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Lund A; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Vilsbøll T; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Steno Diabetes Center Copenhagen, Gentofte, Denmark. Knop FK; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Steno Diabetes Center Copenhagen, Gentofte, Denmark.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Apr 27; Vol. 3 (4), pp. 100299. Date of Electronic Publication: 2021 Apr 27 (Print Publication: 2021).
Embedding assessment of liver fibrosis into routine diabetic review in primary care.
Autorzy:
Mansour D; Queen Elizabeth Hospital, Gateshead, UK.; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. Grapes A; Queen Elizabeth Hospital, Gateshead, UK. Herscovitz M; Bewick Road Surgery, Gateshead, UK. Cassidy P; Teams Medical Centre, Gateshead, UK. Vernazza J; Queen Elizabeth Hospital, Gateshead, UK. Broad A; Raigmore Hospital, Inverness, UK. Anstee QM; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Liver Unit, Newcastle Upon Tyne Hospitals NHS Trust, Freeman Hospital, Newcastle upon Tyne, UK. McPherson S; Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Liver Unit, Newcastle Upon Tyne Hospitals NHS Trust, Freeman Hospital, Newcastle upon Tyne, UK.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Apr 22; Vol. 3 (4), pp. 100293. Date of Electronic Publication: 2021 Apr 22 (Print Publication: 2021).
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank.
Autorzy:
Tavaglione F; Clinical Medicine and Hepatology Unit, Department of Internal Medicine and Geriatrics, Campus Bio-Medico University, Rome, Italy.; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden. De Vincentis A; Internal Medicine Unit, Department of Internal Medicine and Geriatrics, Campus Bio-Medico University, Rome, Italy.; Clinical Lecturer of Internal Medicine, Saint Camillus International University of Health and Medical Sciences, Rome, Italy. Jamialahmadi O; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden. Pujia R; Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy. Spagnuolo R; Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy. Picardi A; Clinical Medicine and Hepatology Unit, Department of Internal Medicine and Geriatrics, Campus Bio-Medico University, Rome, Italy. Morano S; Department of Experimental Medicine, Sapienza University, Rome, Italy. Valenti L; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; Translational Medicine, Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Romeo S; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Wallenberg Laboratory, University of Gothenburg, Gothenburg, Sweden.; Clinical Nutrition Unit, Department of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. Vespasiani-Gentilucci U; Clinical Medicine and Hepatology Unit, Department of Internal Medicine and Geriatrics, Campus Bio-Medico University, Rome, Italy.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2021 Mar 02; Vol. 3 (3), pp. 100262. Date of Electronic Publication: 2021 Mar 02 (Print Publication: 2021).
NASH-related increases in plasma bile acid levels depend on insulin resistance.
Autorzy:
Grzych G; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France. Chávez-Talavera O; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France. Descat A; Univ. Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France. Thuillier D; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190 - EGID, F-59000, Lille, France. Verrijken A; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk/Antwerp, Belgium.; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, 2650 Edegem/Antwerp, Belgium. Kouach M; Univ. Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France. Legry V; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France. Verkindt H; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190 - EGID, F-59000, Lille, France. Raverdy V; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190 - EGID, F-59000, Lille, France. Legendre B; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190 - EGID, F-59000, Lille, France. Caiazzo R; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190 - EGID, F-59000, Lille, France. Van Gaal L; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk/Antwerp, Belgium.; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, 2650 Edegem/Antwerp, Belgium. Goossens JF; Univ. Lille, CHU Lille, EA 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France. Paumelle R; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France. Francque S; Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Wilrijk/Antwerp, Belgium.; Department of Gastroenterology and Hepatology, Antwerp University Hospital, 2650, Edegem, Antwerp, Belgium. Pattou F; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1190 - EGID, F-59000, Lille, France. Haas JT; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France. Tailleux A; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France. Staels B; Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2020 Dec 16; Vol. 3 (2), pp. 100222. Date of Electronic Publication: 2020 Dec 16 (Print Publication: 2021).
Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD.
Autorzy:
Linge J; AMRA Medical AB, Linköping, Sweden.; Department of Health, Medicine and Caring Sciences, Division of Society and Health, Linköping University, Linköping, Sweden. Ekstedt M; Department of Gastroenterology and Hepatology, Linköping University, Linköping, Sweden.; Department of Health, Medicine and Caring Sciences, Division of Diagnostics and Specialist Medicine, Linköping University, Linköping, Sweden. Dahlqvist Leinhard O; AMRA Medical AB, Linköping, Sweden.; Department of Health, Medicine and Caring Sciences, Division of Diagnostics and Specialist Medicine, Linköping University, Linköping, Sweden.; Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden.
Pokaż więcej
Źródło:
JHEP reports : innovation in hepatology [JHEP Rep] 2020 Oct 28; Vol. 3 (1), pp. 100197. Date of Electronic Publication: 2020 Oct 28 (Print Publication: 2021).
Comparison of a point-of-care analyser for the determination of HbA1c with HPLC method.
Autorzy:
Grant DA; Diabetes Research Unit Cymru, Grove Building, Swansea University, Swansea SA2 8PP, UK. Dunseath GJ; Diabetes Research Unit Cymru, Grove Building, Swansea University, Swansea SA2 8PP, UK. Churm R; Diabetes Research Unit Cymru, Grove Building, Swansea University, Swansea SA2 8PP, UK. Luzio SD; Diabetes Research Unit Cymru, Grove Building, Swansea University, Swansea SA2 8PP, UK.
Pokaż więcej
Źródło:
Practical laboratory medicine [Pract Lab Med] 2017 Apr 04; Vol. 8, pp. 26-29. Date of Electronic Publication: 2017 Apr 04 (Print Publication: 2017).
Is there a relationship between the severity of erectile dysfunction and the comorbidity profile in men with late onset hypogonadism?
Autorzy:
Yassin AA; Institute of Urology/Andrology, Norderstedt-Hamburg, Germany ; Dresden International University, Dresden, Germany ; Gulf Medical University School of Medicine, Ajman, United Arab Emirates. Nettleship JE; Department of Human Metabolism, University of Sheffield, UK. Almehmadi Y; Institute of Urology/Andrology, Norderstedt-Hamburg, Germany. Yassin DJ; Klinikum Braunschweig, Department of Urology, Braunschweig, Germany. El Douaihy Y; Institute of Urology/Andrology, Norderstedt-Hamburg, Germany. Saad F; Gulf Medical University School of Medicine, Ajman, United Arab Emirates ; Global Medical Affairs Men's Healthcare, Bayer Pharma AG, Berlin, Germany.
Pokaż więcej
Źródło:
Arab journal of urology [Arab J Urol] 2015 Sep; Vol. 13 (3), pp. 162-8. Date of Electronic Publication: 2015 Jul 07.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies